A warning regarding use in patients with Barrett's esophagus has been added to product information for risedronic acid in the EU.

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1420, 2012-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Warning added to Zyprexa label regarding hyperglycaemia/diabetes

By  

Inpharma, Vol. 1, Iss. 1430, 2004-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

A consensus statement on the use of IV immunoglobulins in patients with autoimmune mucocutaneous blister diseases has been issued

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 430, 2003-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Risedronic acid: Osteonecrosis and/or osteomyelitis in elderly patients: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1304, 2010-01 ,pp. : 31-31

Adis International

Access to resources Recommend Favorite

The hyaluronan product `Suvenyl' [Aventis, Chugai] has been launched in Japan

By  

Inpharma, Vol. 1, Iss. 1255, 2000-01 ,pp. : 26-26

Adis International

Access to resources Recommend Favorite

Alendronic acid/ibandronic acid/risedronic acid: Osteonecrosis of the jaw treated with teriparatide in elderly patients: 6 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1434, 2013-01 ,pp. : 6-7

Adis International

Access to resources Recommend Favorite